The annual conference for the BSGCT is coming up, on 20th June at Royal Holloway, University of London. TestAVec's principle scientific...

Professor Mike Themis of Brunel University London – is the holder of a number of patents relating to gene therapy safety, safety testing...

TestAVec researchers have identified contaminating sequences within HIV-1 viruses used for gene therapy. Researchers from Brunel...

The first patient dosed with in vivo CAR-T gene therapy has now taken place. Interius BioTherapeutics have announced the first use of in...

Further incidences of insertional mutagenesis related cancer have been identified in patients treated for cerebral adrenoleukodystrophy...